UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000053147
Receipt number R000060641
Scientific Title The diagnostic ability for hepatic steatosis using Liver Fat Quantification in EPIC(Philips)
Date of disclosure of the study information 2023/12/20
Last modified on 2023/12/17 20:51:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The diagnostic ability for hepatic steatosis using Liver Fat Quantification in EPIC(Philips)

Acronym

The diagnostic ability for hepatic steatosis using Liver Fat Quantification in EPIC(Philips)

Scientific Title

The diagnostic ability for hepatic steatosis using Liver Fat Quantification in EPIC(Philips)

Scientific Title:Acronym

The diagnostic ability for hepatic steatosis using Liver Fat Quantification

Region

Japan


Condition

Condition

chronic hepatitis

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examin the diagnostic ability for hepatic steatosis using Liver Fat Quantification(LFQ)

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The diagnostic ability for hepatic steatosis of LFQ using MRI-PDFF or hepatic histological evaluation as refarence stabdard

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Chronic hepatitis patients who can sign a informed consent form and express their intention to participate in the study
2. Chronic hepatitis patients who have performed MRI-PDFF or liver biopsy within 3 months of measuring LFQ
3.Chrnonic hepatitis patients performed abdominal ultrasound examination

Key exclusion criteria

1. Chronic hepatitis patients who have difficulty understanding ultrasound examinations and research content
2. Chronic hepatitis patients who cannot lie with supine position in measuring LFQ.
3. Chronic hepatitis patients under 18 years old
4. Chronic hepatitis patinets with ascites.
5. Chronic hepatitis patients who are judged unsuitable by physician

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Takashi
Middle name
Last name Nishimura

Organization

Hyogo Medical University

Division name

Department of Gastroenterology/Ultrasound Imaging Center

Zip code

663-8501

Address

1-1, Mukogawa-cho, Nishinomiya-city, Hyogo prefecture

TEL

0798-45-6472

Email

tk-nishimura@hyo-med.ac.jp


Public contact

Name of contact person

1st name Takashi
Middle name
Last name Nishimura

Organization

Hyogo Medical University

Division name

Department of Gastroenterology/Ultrasound Imaging Center

Zip code

663-8501

Address

1-1, Mukogawa-cho, Nishinomiya-city, Hyogo prefecture

TEL

0798-45-6472

Homepage URL


Email

tk-nishimura@hyo-med.ac.jp


Sponsor or person

Institute

Hyogo Medical University

Institute

Department

Personal name



Funding Source

Organization

Philips Japan

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Division of Hepatology, Department of Internal Medicine, Iwate Medical University

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hyogo Medical University

Address

1-1, Mukogawa-cho, Nishinomiya-city Hyogo prefecture

Tel

0798456111

Email

rinri@hyo-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

兵庫医科大学 消化器内科学/超音波センター(兵庫県)
岩手医科大学 内科学講座消化器内科学分野(岩手県)


Other administrative information

Date of disclosure of the study information

2023 Year 12 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

261

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2022 Year 09 Month 02 Day

Date of IRB

2023 Year 09 Month 30 Day

Anticipated trial start date

2022 Year 10 Month 01 Day

Last follow-up date

2023 Year 10 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

prospective study


Management information

Registered date

2023 Year 12 Month 18 Day

Last modified on

2023 Year 12 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000060641


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name